I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Mazières, J.
1598
results:
Search for persons
X
Format
Online (1595)
Print (3)
Mediatypes
Books (3)
Articles (Online) (616)
Bookchapter (Online) (49)
OpenAccess-fulltext (930)
Languages
german (6)
english (1269)
more...
french (208)
portuguese (2)
latin (5)
spanish (12)
less...
Sorted by: Relevance
Sorted by: Year
?
1
Développement d'un parcours de soins pour les patients trai..:
Chesnel, C.
;
Perriat, S.
;
Puisset, F.
...
Le Pharmacien Clinicien. 59 (2024) 2 - p. e61-e62 , 2024
Link:
https://doi.org/10.1016/..
?
2
81TiP NVL-655, a selective anaplastic lymphoma kinase (ALK)..:
Johnson, M.L.
;
Ou, S-H.I.
;
Felip, E.
...
Journal of Thoracic Oncology. 18 (2023) 4 - p. S86-S87 , 2023
Link:
https://doi.org/10.1016/..
?
3
RWD121 Moment Registry (MET NON SMALL CELL CANCER REGISTRY)..:
Thomas, M.
;
Christopoulos, P.
;
Iams, W.T.
...
Value in Health. 26 (2023) 12 - p. S527 , 2023
Link:
https://doi.org/10.1016/..
?
4
121P MK-7684A (vibostolimab [vibo] plus pembrolizumab [pemb..:
Peled, N.
;
Mazieres, J.
;
Kowalski, D.M.
...
Immuno-Oncology and Technology. 20 (2023) - p. 100593 , 2023
Link:
https://doi.org/10.1016/..
?
5
OA21.05 Tepotinib + Osimertinib in EGFR-mutant NSCLC with M..:
Kim, T.M.
;
Guarneri, V.
;
Jye, V.P.
...
Journal of Thoracic Oncology. 18 (2023) 11 - p. S94 , 2023
Link:
https://doi.org/10.1016/..
?
6
PPD02.03 Tepotinib in Patients with MET Exon 14 (METex14) S..:
Garassino, M.C.
;
Thomas, M.
;
Felip, E.
...
Journal of Thoracic Oncology. 18 (2023) 3 - p. e7-e8 , 2023
Link:
https://doi.org/10.1016/..
?
7
OC-0261 Impact of radiation to host immune system in patien..:
Pasquier, C.
;
Chaltiel, L.
;
Massabeau, C.
...
Radiotherapy and Oncology. 182 (2023) - p. S198-S199 , 2023
Link:
https://doi.org/10.1016/..
?
8
10 Osimertinib versus gefitinib followed by osimertinib in ..:
Masip, J. Remon
;
Besse, B.
;
Aix, S. Ponce
...
Journal of Thoracic Oncology. 18 (2023) 4 - p. S35 , 2023
Link:
https://doi.org/10.1016/..
?
9
OA21.06 ctDNA Dynamics, Prognostic Markers and Resistance M..:
Le, X.
;
Garassino, M.C.
;
Ahn, M.-J.
...
Journal of Thoracic Oncology. 18 (2023) 11 - p. S94-S95 , 2023
Link:
https://doi.org/10.1016/..
?
10
Correction to: Real-world multicentre cohort of first-line ..:
Pons-Tostivint, E.
;
Hulo, P.
;
Guardiolle, V.
...
Cancer Immunology, Immunotherapy. 72 (2023) 6 - p. 1891-1892 , 2023
Link:
https://doi.org/10.1007/..
?
11
Real-world multicentre cohort of first-line pembrolizumab a..:
Pons-Tostivint, E.
;
Hulo, P.
;
Guardiolle, V.
...
Cancer Immunology, Immunotherapy. 72 (2023) 6 - p. 1881-1890 , 2023
Link:
https://doi.org/10.1007/..
?
12
121P Clinical outcomes of compound EGFR mutation in non-sma..:
Brindel, A.
;
Anne-Claire, T.
;
Praz, J. Ruuth
...
ESMO Open. 8 (2023) 1 - p. 101931 , 2023
Link:
https://doi.org/10.1016/..
?
13
Results of screening in early and advanced thoracic maligna..:
Morfouace, M.
;
Novello, S.
;
Stevovic, A.
...
Scientific Reports. 12 (2022) 1 - p. , 2022
Link:
https://doi.org/10.1038/..
?
14
Using Tipifarnib to prevent resistance to targeted therapie..:
Delahaye, C.
;
Brachais, M.
;
Gence, R.
...
European Journal of Cancer. 174 (2022) - p. S55 , 2022
Link:
https://doi.org/10.1016/..
?
15
IFCT-1502 CLINIVO: real-world evidence of long-term surviva..:
Molinier, O.
;
Besse, B.
;
Barlesi, F.
...
ESMO Open. 7 (2022) 1 - p. 100353 , 2022
Link:
https://doi.org/10.1016/..
1-15
Related subjects
Buchsoziologie. Lesersoziologie